|
New innovations in smoking cessation (including varenicline pre-loading;
E-cigarettes; ‘light’ smokers)
Author and presenter:
Hayden McRobbie
Senior Clinical Research Fellow, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK
Abstract
The NHS Stop Smoking Services (NHS SSS) offer the best chances of stopping smoking, however, there remains considerable scope for improvement. There are a number of new innovations and improvements on current treatments that may offer better treatment outcomes for smokers who want to quit.
Recently published studies of varenicline use in smokers with cardiovascular disease (CVD) and Chronic Obstructive Pulmonary Disease (COPD) show that this medicine produces long-term quit rates similar to that seen in a general population of smokers. The e-cigarette is currently being promoted to smokers as a means to reduce or cease their cigarette consumption and anecdotally smokers report using the e-cigarette to help them stop smoking. The electronic cigarette is a non-tobacco device that provides both nicotine and the sensory-motor stimulation similar to that provided by tobacco cigarettes. Published data demonstrates the ability of e-cigarettes to reduce urges to smoke and produce blood nicotine concentrations comparable to that of the nicotine inhalator.
This session will discuss recent innovations in smoking cessation treatment that are relevant to NHS SSS practitioners.
Declaration of interest: Hayden McRobbie has received honoraria for speaking at research symposia and received benefits in kind and travel support from, and has provided consultancy to the manufacturers of smoking cessation medications.
About the presenter
Hayden McRobbie is a Medical Practitioner with international experience in research and treatment. He is based both in London, where he holds a Senior Clinical Research Fellow post at Queen Mary University of London, Barts and The London School of Medicine and Dentistry, and in New Zealand, where he is a Senior Lecturer in the School of Public Health and Psychosocial Studies, Auckland University of Technology and an Honorary Senior Lecturer in the Department of General Practice and Primary Health Care at the University of Auckland.
Dr McRobbie was involved in writing the New Zealand Smoking Cessation Guidelines and developing the ‘ABC approach’, which he
is helping to implement within New Zealand healthcare settings. Dr McRobbie provides smoking cessation treatment and is also involved in training healthcare professionals in smoking cessation. He continues to contribute to numerous expert bodies, committees, working groups and conferences.
Dr McRobbie’s research interests are in the treatment of tobacco dependence and he is developing a focus on the ‘hard to treat’ smoker. He is Assistant Editor of Nicotine and Tobacco Research, Deputy Editor of the Journal of Smoking Cessation, a member of the Society for Research of Nicotine and Tobacco (SRNT) and Vice-president of the Association for the Treatment of Tobacco Use and Dependence (ATTUD).
|
